Cyclobutane derivatives as potent NK1 selective antagonists. 2006

Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
Chemical Research Department, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.

A series of novel cyclobutane derivatives as potent and selective NK1 receptor antagonists is described. Several compounds in this series exhibited high in vitro binding affinity (Ki <or=1 nM), and potent inhibition of central NK1 receptor following oral administration. Syntheses of these compounds are also described herein.

UI MeSH Term Description Entries
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012702 Serotonin Antagonists Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. 5-HT Antagonist,5-HT Antagonists,5-Hydroxytryptamine Antagonist,5-Hydroxytryptamine Antagonists,Antiserotonergic Agent,Antiserotonergic Agents,Serotonin Antagonist,Serotonin Blockader,Serotonin Blockaders,Serotonin Receptor Antagonist,Serotonin Receptor Blocker,Antagonists, 5-HT,Antagonists, 5-Hydroxytryptamine,Antagonists, Serotonin,Serotonin Receptor Antagonists,Serotonin Receptor Blockers,5 HT Antagonist,5 HT Antagonists,5 Hydroxytryptamine Antagonist,5 Hydroxytryptamine Antagonists,Agent, Antiserotonergic,Agents, Antiserotonergic,Antagonist, 5-HT,Antagonist, 5-Hydroxytryptamine,Antagonist, Serotonin,Antagonist, Serotonin Receptor,Antagonists, 5 HT,Antagonists, 5 Hydroxytryptamine,Antagonists, Serotonin Receptor,Blockader, Serotonin,Blockaders, Serotonin,Blocker, Serotonin Receptor,Blockers, Serotonin Receptor,Receptor Antagonist, Serotonin,Receptor Antagonists, Serotonin,Receptor Blocker, Serotonin,Receptor Blockers, Serotonin
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D064729 Neurokinin-1 Receptor Antagonists Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. Neurokinin 1 Receptor Antagonist,Neurokinin-1 Receptor Antagonist,Neurokinin-1 Receptor Blocker,Neuroleukin-1 Receptor Blocker,Substance P Receptor Antagonist,Substance P Receptor Blocker,Tachykinin Receptor 1 Antagonist,Tachykinin Receptor 1 Blocker,Neurokinin-1 Receptor Blockers,Neuroleukin-1 Receptor Blockers,Substance P Receptor Antagonists,Substance P Receptor Blockers,Tachykinin Receptor 1 Antagonists,Tachykinin Receptor 1 Blockers,Antagonist, Neurokinin-1 Receptor,Antagonists, Neurokinin-1 Receptor,Blocker, Neurokinin-1 Receptor,Blocker, Neuroleukin-1 Receptor,Blockers, Neurokinin-1 Receptor,Blockers, Neuroleukin-1 Receptor,Neurokinin 1 Receptor Antagonists,Neurokinin 1 Receptor Blocker,Neurokinin 1 Receptor Blockers,Neuroleukin 1 Receptor Blocker,Neuroleukin 1 Receptor Blockers,Receptor Antagonist, Neurokinin-1,Receptor Antagonists, Neurokinin-1,Receptor Blocker, Neurokinin-1,Receptor Blocker, Neuroleukin-1,Receptor Blockers, Neurokinin-1,Receptor Blockers, Neuroleukin-1

Related Publications

Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
September 2005, Bioorganic & medicinal chemistry letters,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
February 2006, Bioorganic & medicinal chemistry letters,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
September 2015, Bioorganic & medicinal chemistry letters,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
January 2009, Bioorganic & medicinal chemistry letters,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
April 2006, Bioorganic & medicinal chemistry letters,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
January 2011, Journal of medicinal chemistry,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
January 2014, Chemical & pharmaceutical bulletin,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
November 2006, Journal of medicinal chemistry,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
January 2011, Bioorganic & medicinal chemistry,
Michelle Laci Wrobleski, and Gregory A Reichard, and Sunil Paliwal, and Sapna Shah, and Hon-Chung Tsui, and Ruth A Duffy, and Jean E Lachowicz, and Cynthia A Morgan, and Geoffrey B Varty, and Neng-Yang Shih
August 2022, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!